BCL2 and pachyonychia congenita: Consistent with this, our studies supported that the BCL2-positive neuroendocrine PC cell line NCI-H660 was sensitive to venetoclax with induction of apoptosis; however, there was limited antitumor activity when BCL2-expressing PDX CRPC models were treated in vitro.